Bacil Pharma Limited (BOM:524516)

Bacil Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	28.57	0.41	0.29	2.3	0.99
Trading Asset Securities	-	-	-	1.91	0.76	1.39
Cash & Short-Term Investments	15.94	28.57	0.41	2.2	3.06	2.38
Cash Growth	1256.43%	6788.85%	-81.12%	-28.26%	28.71%	7.33%
Other Receivables	-	-	-	-	-	0
Receivables	-	-	-	-	-	0
Other Current Assets	-	0.5	0.11	0.09	0.1	0.64
Total Current Assets	-	29.07	0.52	2.29	3.16	3.02
Property, Plant & Equipment	-	-	0.06	0.08	0.11	0.15
Long-Term Investments	-	213.57	6.11	2.36	2.36	2.36
Long-Term Deferred Tax Assets	-	0.54	0.56	1.17	1.08	1.08
Other Long-Term Assets	-	0	-	0	-0	25
Total Assets	-	256	13.26	11.27	12.72	40.88
Accounts Payable	-	0.04	0.04	0	0.11	0.11
Accrued Expenses	-	-	0.09	0.06	0.02	0.09
Short-Term Debt	-	1.64	0.98	0.21	0.33	1.76
Current Unearned Revenue	-	-	-	-	-	25
Other Current Liabilities	-	0.01	0.02	0.01	0.02	0.01
Total Current Liabilities	-	1.69	1.13	0.28	0.47	26.97
Other Long-Term Liabilities	-	0	-	0	-	-
Total Liabilities	-	1.69	1.13	0.28	0.47	26.97
Common Stock	-	139.7	58.9	58.9	58.9	58.9
Retained Earnings	-	114.61	-53.14	-54.28	-53.03	-51.36
Comprehensive Income & Other	-	-	6.37	6.37	6.37	6.37
Shareholders' Equity	263.5	254.31	12.13	10.99	12.24	13.91
Total Liabilities & Equity	-	256	13.26	11.27	12.72	40.88
Total Debt	-	1.64	0.98	0.21	0.33	1.76
Net Cash (Debt)	15.94	26.93	-0.57	1.99	2.73	0.62
Net Cash Growth	-	-	-	-27.11%	338.69%	17.88%
Net Cash Per Share	1.29	4.27	-0.10	0.33	0.46	0.11
Filing Date Shares Outstanding	13.07	14.35	5.89	5.89	5.89	5.89
Total Common Shares Outstanding	13.07	14.35	5.89	5.89	5.89	5.89
Working Capital	-	27.39	-0.61	2.01	2.69	-23.95
Book Value Per Share	19.09	17.72	2.06	1.87	2.08	2.36
Tangible Book Value	263.5	254.31	12.13	10.99	12.24	13.91
Tangible Book Value Per Share	19.09	17.72	2.06	1.87	2.08	2.36
Machinery	-	0.59	0.55	0.59	0.59	0.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.